Taken together, these results suggest that activation of YAP‐CDK6 signaling by XMU‐MP‐1 delays the senescence of astrocytes in vitro and in vivo, and thereby improving the cognitive function of aged mice and AD model mice. Here, CDK6 is linked to Alzheimer disease.